Better Therapeutics Issues Investor Presentation with Cautions
PremiumCompany AnnouncementsBetter Therapeutics Issues Investor Presentation with Cautions
6M ago
Better Therapeutics CEO Discusses Future on Bloomberg TV
Premium
Company Announcements
Better Therapeutics CEO Discusses Future on Bloomberg TV
7M ago
Better Therapeutics enters rebate pact with PBM for AspyreRx diabetes treatment
Premium
The Fly
Better Therapeutics enters rebate pact with PBM for AspyreRx diabetes treatment
8M ago
Better Therapeutics reports Q3 EPS (15c), consensus (21c)
PremiumThe FlyBetter Therapeutics reports Q3 EPS (15c), consensus (21c)
11M ago
Better Therapeutics announces topline findings from AspyreRx analysis
Premium
The Fly
Better Therapeutics announces topline findings from AspyreRx analysis
11M ago
Better Therapeutics’ LivVita study met primary endpoint by reducing liver fat
Premium
The Fly
Better Therapeutics’ LivVita study met primary endpoint by reducing liver fat
12M ago
Better Therapeutics issues $6.7M in common stock under its at-the-market program
PremiumThe FlyBetter Therapeutics issues $6.7M in common stock under its at-the-market program
1y ago
Better Therapeutics receives FDA authorization for AspyreRx
Premium
The Fly
Better Therapeutics receives FDA authorization for AspyreRx
1y ago
Is BTTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is BTTX a Buy, Before Earnings?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100